229 related articles for article (PubMed ID: 37245004)
1. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts.
Zhao N; Li QX; Wang YF; Qiao Q; Huang HY; Guo CB; Guo YX
BMC Oral Health; 2023 May; 23(1):330. PubMed ID: 37245004
[TBL] [Abstract][Full Text] [Related]
2. Low-level laser therapy prevents medication-related osteonecrosis of the jaw-like lesions via IL-1RA-mediated primary gingival wound healing.
Zheng Y; Dong X; Chen S; He Y; An J; Liu M; He L; Zhang Y
BMC Oral Health; 2023 Jan; 23(1):14. PubMed ID: 36627695
[TBL] [Abstract][Full Text] [Related]
3. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
4. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw.
Adachi N; Ayukawa Y; Yasunami N; Furuhashi A; Imai M; Sanda K; Atsuta I; Koyano K
Sci Rep; 2020 Mar; 10(1):5620. PubMed ID: 32221325
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction.
Park KM; Cheong J; Pang NS; Kim KD; Lee JS; Park W
BMC Oral Health; 2023 Aug; 23(1):561. PubMed ID: 37573298
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Bone Necrosis around Tooth Extraction Socket in a MRONJ-like Mouse Model by E-rhBMP-2 Containing Artificial Bone Graft Administration.
Tanaka Y; Aung KT; Ono M; Mikai A; Dang AT; Hara ES; Tosa I; Ishibashi K; Ono-Kimura A; Nawachi K; Kuboki T; Oohashi T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884630
[TBL] [Abstract][Full Text] [Related]
8. Chronic Periodontal Infection and Not Iatrogenic Interference Is the Trigger of Medication-Related Osteonecrosis of the Jaw: Insights from a Large Animal Study (PerioBRONJ Pig Model).
Troeltzsch M; Zeiter S; Arens D; Nehrbass D; Probst FA; Liokatis P; Ehrenfeld M; Otto S
Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241232
[No Abstract] [Full Text] [Related]
9. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
10. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
11. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
12. Case series of medication-related osteonecrosis of the jaw (MRONJ) patients prescribed a drug holiday.
Hamid A; Thomas S; Bell C; Gormley M
Br J Oral Maxillofac Surg; 2023 Apr; 61(3):227-232. PubMed ID: 36935312
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
[TBL] [Abstract][Full Text] [Related]
14. Influence of induced infection in medication-related osteonecrosis of the jaw development after tooth extraction: A study in rats.
Bolette A; Lecloux G; Rompen E; Albert A; Kerckhofs G; Lambert F
J Craniomaxillofac Surg; 2019 Feb; 47(2):349-356. PubMed ID: 30595476
[TBL] [Abstract][Full Text] [Related]
15. Exosomes Derived from Adipose Tissue-Derived Mesenchymal Stromal Cells Prevent Medication-Related Osteonecrosis of the Jaw through IL-1RA.
Zheng Y; Dong X; Wang X; Wang J; Chen S; He Y; An J; He L; Zhang Y
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240036
[TBL] [Abstract][Full Text] [Related]
16. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
17. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the jaw: A disease of significant importance for older patients.
Boston B; Ipe D; Capitanescu B; Gresita A; Hamlet S; Love R; Hadjiargyrou M; Huang CL; Nusem I; Miroiu RI; Popa-Wagner A; Warnke PH; Petcu EB
J Am Geriatr Soc; 2023 Aug; 71(8):2640-2652. PubMed ID: 37224415
[TBL] [Abstract][Full Text] [Related]
19. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: A major adverse effect of bisphosphonate therapy.
Tamari T; Elimelech R; Cohen G; Cohen T; Doppelt O; Eskander-Hashoul L; Zigdon-Giladi H
Sci Rep; 2019 Dec; 9(1):18896. PubMed ID: 31827217
[TBL] [Abstract][Full Text] [Related]
20. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
